Company intelligence / Profile preview

Hannibal Innovation

Copenhagen, Denmark

Ownership: Private
Development stage: Other

Overview

Hannibal Innovation is an early-stage life sciences investor and company builder that partners with drug discovery organizations to create new therapeutics companies; it is not itself a therapeutic developer, so it has no direct clinical-stage pipeline.[2][4][5]

Industry: Investors

Partnerships

Vernalis Research (a subsidiary of HitGen)

Beyond the preview

Go deeper on Hannibal Innovation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hannibal Innovation.

Explore the full profile